Pay in 4 interest-free payments of $7.08 Learn more
Ships within 48 hours · Estimated delivery Aug 29 - Sep 3
See availability The latest news, articles, and resources, sent to your inbox weekly.
That raises the question of whether and how GLP-1R agonists, which were initially developed for use in the rest of the body, make their way into the brain
These data do not simply add more power to obesity treatment
Insurance limitations Many patients struggle with coverage restrictions
Adipose tissue NAD(+) biology in obesity and insulin resistance: From mechanism to therapy
MetS, metabolic syndrome
US$ 21.84
US$ 23.20
US$ 21.22
US$ 27.62
US$ 28.75
